Persephone Biosciences Announces AI-Driven Microbiome Therapeutic and Diagnostic Programs for COVID-19

Press Release

January 2020 Special Issue Cover 

GEN 2020

Microbiome Targeted Therapeutics May Have Role in COVID-19 Fight

NBC 7 News

Developing a COVID-19 Therapeutic: Interview with Stephanie Culler CEO and co-founder of Persephone Biosciences   

LinkedIn

Collaboration with Curebase on CURE-19 Featured on Geneonline

Geneonline 2020

Persephone Biosciences: Featured in GEN “Vanquishing the Virus” for COVID-19 Efforts

GEN 2020

SDBN BUZZ Podcast: Does the Gut Microbiome Affect the Response to Immuno-Therapy?

SDBN 2019

Panelist: “Hot Technology Event: Microbiome Products Beyond FMT- Challenges and Opportunities

Biocom 2019

Inspired by the Microbiome: can poop pills and gut bugs help boost cancer immunotherapy’s effects?

C&EN News

How the Microbiome Could Be the Key to New Cancer Treatments

SMITHSONIAN 2019

Congratulations to Our 2019 Biocom Catalyst Award Winners

biocom

CNBC’s Advancements TV with Ted Danson

CNBC 2019

Designing Microbiome Therapeutics to Help Cure Cancer

TedX 2018

Our Favorite Start-ups From Y-Combinator W18 Demo Day 2

techcrunch